Robert Wendel Naumann
0000-0002-2739-165X
Levine Cancer Institute, Atrium Health
80 papers found
Refreshing results…
Enhanced recovery after surgery (ERAS) protocol is associated with lower post-operative opioid use and a reduced office burden after minimally invasive surgery
The Benefits of Laparoscopic Radical Hysterectomy for Cervical Cancer: Res Ipsa Loquitur?
Impact of a Clinical Genomics Program on Trial Accrual for Targeted Treatments: Practical Approach Overcoming Barriers to Accrual for Underserved Patients
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Opportunistic Salpingectomy at Time of Nongynecologic Elective Procedures Could Reduce Ovarian Cancer–Related Costs and Mortality
Factors Associated with Same Day Discharge after Laparoscopic Surgery in Gynecologic Oncology
Perioperative Recovery and Narcotic Use in Laparoscopic versus Robotic Surgery for Endometrial Cancer
The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage
RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer
Comparison of Perioperative Outcomes between Minimally Invasive Sentinel Node Biopsy and Full Lymphadenectomy for Endometrial Cancer
Pre-emptive Non-narcotic Pain Medication before Minimally Invasive Surgery in Gynecologic Oncology
Vaginal Cuff Closure During Laparoscopic Hysterectomy Comparing the EndoStitch and RD-180 Suturing Devices
Re-evaluating “Success” as It Pertains to Surgical Trials
Advances in immunotherapy for cervical cancer
Outcomes of minimally invasive versus open radical hysterectomy for early-stage cervical cancer incorporating 2018 FIGO staging
Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis
Molecular variations in uterine carcinosarcomas identify therapeutic opportunities
European society of medical oncology (ESMO) 2019 meeting report features practice changing data in gynecologic malignancies
Corrigendum to “Phase III trials in ovarian cancer: The evolving landscape of front line therapy” [Gynecol. Oncol. 153 (2019) 436–444]
Workplace Harassment and Discrimination in Gynecology: Results of the AAGL Member Survey
Missing publications? Search for publications with a matching author name.